IndraLab

Statements

SSRI fluoxetine activates KCNK2. 1 / 1

| 1

reach

"Spadin was administered 30 min before the test by intracerebroventricular (i.c.v.), intravenous (i.v.), or intraperitoneal (i.p.) route at doses of 10 -4 to 10 -8 M. Its effects were compared to the behavior observed in kcnk2 -/- mice and in wild-type mice treated with the efficient SSRI fluoxetine (i.p., 3 mg/kg)."

20405001

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

SSRI fluoxetine activates KCNK2. 1 / 1

INDRA sources:

Databases

Reading